Life Sciences consulting leader with 20+ years of experience; President of BioKatalyst, a non-profit biopharma executives association
See our latest Oncology Pulse! (Ironman vs. Superman?) Meet the Bluestar oncology team at ASCO!
ADCs and radiopharmaceuticals have re-emerged as modalities of high interest in oncology licensing and acquisition – will they be the next wave of breakthroughs or represent a flight to safety in light of the challenges of finding the next hot target and the IRA? Here's a link to our latest Oncology Pulse: https://lnkd.in/gJ4xUFUB Also, ASCO24 is one week away, and abstracts drop today. Our team is looking forward to sifting through the data to understand the implications. We hope to see you in Chicago!